Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Paraganglioma

Below is an extended Paraganglioma patents listing. Click here to return to the Paraganglioma main in depth entry.

Patents :

US Patent No.Title
7138123 Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
7276241 Methods of treating a tumor that expresses APRIL by administering BCMA
7291495 .beta.-Secretase variant
7297525 Composition employing a novel human kinase
7304036 Methods and compositions for the treatment of gastrointestinal disorders
7332281 Therapeutic targets in cancer
7332288 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
7351805 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
7358042 Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7368527 HADDE71 polypeptides
7368531 Human secreted proteins
7262288 Nucleic acids encoding human telomerase reverse transcriptase and related homologs
7241769 Pyrimidines as PLK inhibitors
7232805 Cobalamin conjugates for anti-tumor therapy
7138370 Specific binding agents of human angiopoietin-2
7151162 Nuclear protein
7157419 Growth factor binding molecules
7163797 50 human secreted proteins
7163801 Methods for determining the prognosis for cancer patients using tucan
7195911 Mammalian cells that have increased proliferative capacity
7199234 Regulatory segments of the human gene for telomerase reverse transcriptase
7205275 Methods of treatment using specific binding agents of human angiopoietin-2
7208151 Tweak receptor agonists as anti-angiogenic agents
7226748 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7371727 Methods and compositions for the treatment of gastrointestinal disorders
7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
7521053 Angiopoietin-2 specific binding agents
7528142 Aminopyrimidines useful as kinase inhibitors
7538095 Genetic inhibition by double-stranded RNA
7538252 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
7550256 Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7556964 Transgenic cell and gene recombinant animal having a mutant SDHC gene derived from mammals
7560437 Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
7560438 Genetic inhibition by double-stranded RNA
7569561 2,4-diaminopyrimidines useful for treating cell proliferation diseases
7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase
7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
7507410 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
7501255 Levels of Pin1 in normal and cancerous tissue
7405227 Treatment of cancer
7411051 Antibodies to HDPPA04 polypeptide
7413851 Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7413864 Treating cancer using a telomerase vaccine
7442778 Modified Fc molecules
7449555 Antibodies of angiogenesis inhibiting domains CD148
7459522 Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use
7459531 50 Human secreted proteins
7473528 Method for the detection of Chagas disease related gene transcripts in blood
7494979 Method for treating congestive heart failure and other disorders
7585626 Methods for nucleic acid amplification

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.